Oncoheroes Biosciences, a biotech focused exclusively on advancing new therapies for children with cancer, receives another endorsement from a childhood cancer non-profit. The support received by The Gregory Foundation for Cancer Research will help accelerate the clinical drug development of volasertib, one of Oncoheroes’ assets, propelling it into a Phase Ib-II clinical trial for Rhabdomyosarcoma.

Read more: https://oncoheroes.com/insights-news-1/2020/3/3/the-gregory-foundation-for-cancer-research-joins-oncoheroes-biosciences-to-defeat-childhood-cancer